Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
about
COP9-associated CSN5 regulates exosomal protein deubiquitination and sortingDynamic regulation of the COP9 signalosome in response to DNA damageThe Role of the COP9 Signalosome and Neddylation in DNA Damage Signaling and RepairRegulation of the human catalytic subunit of telomerase (hTERT).JAB1/CSN5: a new player in cell cycle control and cancerTargeting Jab1/CSN5 in nasopharyngeal carcinomaCOPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR.Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study.Psoriasin (S100A7) associates with integrin β6 subunit and is required for αvβ6-dependent carcinoma cell invasion.S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.High-throughput profiling of tissue and tissue model microarrays: Combined transmitted light and 3-color fluorescence digital pathology.Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients.Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.
P2860
Q24315611-58A5C09B-8D4D-4CAD-A0F7-A577050B7FE2Q24319983-D024D1D1-BC99-460B-AB02-165EA6F09966Q26782011-9B38637B-FE2D-4043-963E-A61C821B8854Q34180715-68DE1C52-CE8A-4CDD-B5AA-8C84025BDFCDQ34292695-98B8437B-29F8-49DB-8C54-345C4D90FBF7Q36327912-3F01C109-B4B4-4521-9EA6-6D21DF5DF9E8Q37063329-5732B191-C416-4283-A382-E03DAD22BE01Q38708092-A689FA86-9D70-4344-91E9-BEC2101FDC0CQ39555290-1A5FE1C1-9884-4F4E-BB15-F4346A0F2FC9Q39623720-687F107B-8604-4345-8661-773551A2CEABQ39747948-63BACF18-D21A-49F1-88AA-BEFD5DCECF48Q39766695-4E2072B0-6C0A-47E4-9E45-9A725725C247Q47153479-EDB6DC7D-70B1-45D1-A5D9-D9D9CEE7762CQ52657204-06FD8CB9-BECF-4E45-BEEA-917161AC3BDC
P2860
Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
@en
Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
@nl
type
label
Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
@en
Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
@nl
prefLabel
Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
@en
Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
@nl
P2093
P2860
P356
P1476
Jab1 is a target of EGFR signaling in ERalpha-negative breast cancer.
@en
P2093
Jenny E Chu
Jiaxu Wang
Melanie Olson
Nathan R West
Peter H Watson
Rebecca O Barnes
P2860
P2888
P356
10.1186/BCR2105
P577
2008-06-06T00:00:00Z
P5875
P6179
1007459824